V6 Anti-Human TNFA (Certolizumab)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
TNFA
Purification
Protein A
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Sterility
0.2 μM filtered
Isotype
Human Fab'-G1-kappa
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6506362-01 0.1 mL
YBOX1, NT (Nuclease-sensitive Element-binding Protein 1, Y-box-binding Protein 1, Y-box Transcription Factor, YB-1, CCAAT-binding, Transcription Factor I Subunit A, CBF-A, Enhancer Factor I Subunit A, EFI-A, DNA-binding Protein B, DBPB, YBX1, NSEP1, YB1)
Sign In for Pricing
View Details MBS6506362-02 5x 0.1 mL
YBOX1, NT (Nuclease-sensitive Element-binding Protein 1, Y-box-binding Protein 1, Y-box Transcription Factor, YB-1, CCAAT-binding, Transcription Factor I Subunit A, CBF-A, Enhancer Factor I Subunit A, EFI-A, DNA-binding Protein B, DBPB, YBX1, NSEP1, YB1)
Sign In for Pricing
View Details 
MBS1120419-01 0.02 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype O:1b Protein RnfH (rnfH)
Sign In for Pricing
View Details MBS1120419-02 0.1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype O:1b Protein RnfH (rnfH)
Sign In for Pricing
View Details